Click on headlines below to download research

Awaiting for eventful 2019
Oryzon Genomics | 18/07/2018

The next year is shaping up to be transformative for Oryzon with two data readouts from Phase IIa trials with ORY-2001 in Alzheimer’s disease (AD)…

RESTORE trial completed, data this quarter
Bionomics | 18/07/2018

Bionomics announced on 9 July 2018 that it had completed treatment in its 193-patient Phase II clinical study of BNC210 for post-traumatic stress disorder…

Shifts in US CRC screening; major catalysts in H2
VolitionRx | 18/07/2018

VolitionRx has broad R&D programme and expects to announce major milestones in the coming months, culminating with CE marking and launch of both colorectal…

Both divisions slightly ahead of expectations
Carr’s Group | 18/07/2018

The recovery in both US feed block sales and the UK manufacturing businesses noted at Carr’s Group’s AGM in January has continued through to…

Domino’s in Russia and Turkey
DP Eurasia | 18/07/2018

DP Eurasia’s (DPEU’s) H118 trading statement highlighted the company’s progress in tapping the under-penetrated Russian and Turkish pizza…